BWH-85®
Better Way Health
Better Way Health · Founded 1998
Most people have never heard of it. That's about to change. Better Way Health has spent 26 years building the world's most defensible position around the most studied immune ingredient on earth — trademarked, clinically proven, and expanding across five channels.
Dr. Václav Větvička — the world's leading beta glucan researcher at the University of Louisville — has published 11 independent head-to-head comparison studies evaluating 50+ commercial beta glucan products. BWH-85® (published as Glucan #300) finished first in every single one.
The performance advantage comes down to one word: purity. BWH-85® is 85%+ pure. The competition is ~70%. That 15-point gap is the mechanistic explanation for why the margin holds in every study, every endpoint, every year.
In all tests employed in our study, Glucan #300 was the most active.Dr. Větvička — Anticancer Research 2018 · 16 glucans tested
Glucan #300 was consistently the most active glucan from all.Dr. Větvička — Journal of Clinical Medicine 2026 · 9 glucans tested
Head-to-Head Data
independent comparison studies published by Dr. Větvička — #1 in every single one
more IL-2 cytokine production vs. the next-best competitor (910.8 vs. 508.1 pg/mL)
reduction in lung metastases vs. PBS control in the 2026 head-to-head study
more effective than the product Lumati had been selling. They switched on the data. First order: $40,000.
Registered: US · China · India · UK · EU
In a supplement industry built on generic names and commodity positioning, we built a brand vocabulary no competitor can touch. Four registered trademarks. Five global jurisdictions. A 26-year-old story that belongs entirely to us.
This is not a product trademark. This is an ingredient trademark — one of the most defensible forms of IP in the supplement industry. Any product claiming to contain BWH-85® must license from us or face federal trademark infringement. When B2B partners like TSI Group formulate with our ingredient, they carry our registered name into their products. When Dr. Větvička publishes studies on Glucan #300 and we are the only commercial source at 85%+ purity, the scientific identity and the brand identity are the same thing.
The trust umbrella. Twenty-six years of equity built on a single promise: a better way to be well. Every new channel, every new product, every new partnership inherits this brand's reputation. It is not a name — it is a compounding asset.
Registered · US · Est. 1998
A category name, not a product name. "Immune Ready" defines the state of preparedness — the daily outcome our customers are buying. It spans kids' gummies, drink mixes, and future formulations. The brand expands; the trademark holds.
Registered · US, EU
The daily habit is ours to own. This trademark captures the subscription behavior at its core — the commitment to immune health as a practice, not a reaction. It links product names to a philosophy that no competitor has claimed.
Registered · US
Owning the Story
When practitioners say "I recommend BWH-85," they're speaking our trademark. When B2B partners say "formulated with BWH-85," they carry our registered name. That's not marketing — that's ownership.
Most supplement brands own a product. We own a vocabulary. BWH-85® is the name researchers publish, practitioners prescribe, and B2B partners license. Immune Ready® is the category a generation of parents is learning to trust. Daily Immune Readiness® is the habit 7,663 subscribers are already living. And Better Way Health® is the 26-year-old promise that all of it rests on. You cannot buy a shortcut to any of that. You build it or you don't have it.
We assembled this board with one criteria: these are the people who have actually studied beta glucan, trained thousands of clinicians, and staked their reputations on nutritional immunology for decades. Every seat was chosen for depth, not proximity. The result is a validation signal that goes well beyond an endorsement.
SAB Chair · Better Way Health
ND · Bastyr University · USA Today Bestselling Author
Dr. Strand served as Vice President of Clinical Education and Research at Better Way Health, where she built the scientific narrative behind BWH-85® and developed the clinical education programs that drive practitioner adoption. A naturopathic doctor trained at Bastyr University, she has spent her career at the intersection of microbiome health, autoimmunity, botanical therapeutics, and immune resilience. She is the USA Today bestselling author of Healthy Kids, Happy Kids and a recognized authority in integrative pediatric health. Dr. Strand doesn't endorse products — she builds the science underneath them.
External Scientific Advisors
Robert Rountree
MD · Integrative Immunology
IFM Core Faculty · Chief Medical Advisor, Thorne HealthTech
IFM Linus Pauling Functional Medicine Award recipient. Core faculty since the Institute for Functional Medicine's founding. Author of Immunotics — the landmark clinical text on evidence-based immune supplementation. Over 40 years in nutritional immunology, Dr. Rountree has specifically championed beta glucans as a "workhorse nutrient" that trains innate immune cells to respond without triggering excess inflammation — the exact mechanism BWH-85® is built on.
Immunotics Author · IFM Linus Pauling Award
Chris D'Adamo
PhD · Epidemiology
Director, Center for Integrative Medicine — University of Maryland School of Medicine
Director of UMSOM's Center for Integrative Medicine — the world's first academic integrative medicine center, now home to $50M+ in research funding and 900+ peer-reviewed publications. An epidemiologist with 60+ published studies, Dr. D'Adamo has conducted specific research into beta glucan and immune resilience. His presence places BWH-85® in a rigorous academic context that institutional buyers and formulators require.
World's 1st Academic Integrative Medicine CenterMichelle Perro
MD, DHom · Integrative Pediatrics
Integrative Pediatrician · Mill Valley, CA
40+ years of clinical practice, integrating board-certified pediatric medicine with homeopathy and environmental health. A leading voice on how environmental toxins, pesticides, and food system changes compromise children's immune systems, Dr. Perro brings the patient-facing lens to this board: how does BWH-85® translate in real patients, across pediatric and adult immune challenges, at the point of care.
40+ Years Clinical · Environmental Immune HealthBefore either had joined this board, Dr. Rountree and Dr. D'Adamo co-appeared on Dr. Kara Fitzgerald's podcast in December 2025 — an episode titled "The Hidden Immune Signal Accelerating Aging — The Beta Glucan That Fixes It." Two of BWH's three external advisors had already, independently, staked their public reputations on the same ingredient. That's not a recruitment coincidence. That's convergence.
Five-Star Reviews
The supplement industry sells trust. Most companies borrow it from celebrity endorsements, paid placements, and slick packaging. We earned ours the hard way — one customer at a time, over eight consecutive years, in a category where most customers have been burned before. Ten thousand five-star reviews isn't a marketing metric. It's an asset. It lives on every platform, compounds daily, and no competitor can replicate or buy it away from us. It tells the story of our brand promise better than any copy we could ever write.
I have a handicapped daughter whose white blood cell count is half the lowest normal level — her doctors can't explain why she's not sick all the time. She hasn't had anything more than a single cold in at least four or five years. There is one supplement I NEVER skip: the Beta 1,3D Glucan. It's my belief it makes a huge difference for her health.
I have been taking beta-glucan for several years. Each year before I started, I would get sick for a minimum of two weeks. Since taking beta-glucan I have been doing well and staying healthy. I can really feel the difference. I will continue taking this product every morning for many years to come.
It absolutely warms my heart to know that I have found an honest company making amazing products. I love that I no longer have to spend days, weeks, and months researching on the internet. I have literally spent years trying to find products that are excellent quality and that I know I can trust. It is extremely difficult to find a company that is completely honest. Better Way Health is that company.
The research behind this product and the clinical studies provide me with the greatest confidence that I am buying the best product available. Their service and delivery are outstanding. I'm not guessing — I know exactly what I'm getting and why it works.
The customer service team figured out exactly how much of each supplement we need, signed us up for subscription delivery, and every month the exact amount appears at our door. I'm the family nurse and default caretaker — this takes a great load off my mind. They're motivated by the desire to help their customers, not fleece them. Hooking up with this company is one of the best things that happened to us on this journey.
By far the best customer service of any company I've ever dealt with. You always get a real person and they are so accommodating, helpful, and genuinely NICE. Thank you for caring enough to hire people who also care. That is a rarer thing than it should be, and it makes a huge difference.
This is a brand asset no one can take from us.
A competitor can match our price. They can copy our packaging. They can hire scientists and run studies. What they cannot do is manufacture eight years of authentic customer relationships documented across tens of thousands of verified reviews on the most trusted review platforms in the world. The consistency of this record — 4.9 stars across 8 consecutive years, in a cynical category, from real patients and caregivers — is the compounding proof of a brand promise that gets kept, every day, at scale.
Revenue has grown every single year. Subscription as a percentage of total went from 51% in 2023 to 74% in 2025 — and keeps climbing. This isn't a marketing story. It's a retention story.
The webinar is the growth flywheel. ROAS went from 1.3× to 3.5×+. 40+ health topics, each led by a credentialed KOL. The system now runs continuously — a non-webinar week is visible in the subscriber numbers within days.
You guys have found something really cool here. If I was looking at buying your business, this would be something I'd be really interested in.John Quilter — Business Advisor, January 2026
Revenue Trajectory
New Subscriber Acquisition
New subscriber acquisition has grown every year since 2022. 2025 was the all-time record. 2026 is tracking in line with 2025's underlying pace — month-for-month comparisons are essentially flat to slightly ahead. The 2025 total was lifted by a large Black Friday spike in November; with Q4 still ahead for 2026, the full-year projection is 3,400+.
Across 25,000+ cancelled subscriptions, the #1 reason: "I already have more than I need." Not price. Not a competitor. Not dissatisfaction. Customers pause because they're over-inventoried — then typically return. These aren't churn events. They're pause events.
Four Product Lines
Immune health & cancer support. The product that built the company. Mature cohorts show 2.2% monthly churn after 6–8 years on product.
Anti-aging skin health. Cold-traffic validated Feb 2026 — 99 new subscribers from zero-brand-awareness audiences. Highest LTV:CAC in the line.
Biological age reversal. TruDiagnostic study reversed aging in 7 of 11 organ systems. 2,508 subscribers already self-administering before the dedicated funnel launches.
Children's immune health. 6 independent clinical trials. Active discussions to embed directly into Dartmouth Children's Hospital clinical protocols via Fullscript.
14 months. 65 weekly leadership meetings. A single thesis emerged: the webinar is the growth flywheel. ROAS went from 1.3× to 3.5×+. The engine now runs 40+ health topics, each led by a credentialed KOL.
Rebuilt the Entire Stack
Migrated from WebinarJam to AEvent + Zoom. Brought in Ed O'Keefe as consultant. Removed the 1-bottle option — subscribe or 3-pack only. Subscription rates jumped from ~80% to 95%+.
Affiliate-Driven Traffic Proved Out
Karlfeldt $10K sponsorship returned $27,200 day-of. First-ever Restream simulcast to YouTube + Instagram. First MD in 26 years (Roundtree). 79% new-customer rate.
Black Friday Live. $70K in 3 Hours.
Invented the multi-speaker live telethon format. Annette Reeder (500K YouTube subscribers) drove $50K+ in a single 1-hour webinar — 89.3% new customers.
"All the growth right now is coming from the webinars."
Stagall webinar AI-graded 97% A-. January total revenue $540K. Non-webinar weeks visibly drop subscriber numbers within days. The webinar is the heartbeat. Studio 85 begins construction.
Operationalized. 8-Week Planning Buffer. In-House Studio.
Studio 85 completed at The Barn — redundant internet, UPS power, pro production. Jocelyn Strand onboarded. Goldcare partnership (20% commission) confirmed. Weekly cadence is now the operating standard.
Practitioners won't recommend a product their patients can find on Amazon. Full stop. That's why BWH Labs exists as a completely separate brand — practitioner-exclusive, unavailable to retail consumers, purpose-built for the clinical relationship.
The Fullscript platform is how functional medicine practitioners, naturopaths, and integrative MDs order for their patients. Getting embedded there with a practitioner-exclusive brand backed by 11 head-to-head studies is a structural advantage no D2C brand can replicate.
BWH Labs launched in 2026 with three things in place on day one: Dr. Jocelyn Strand (VP Education) with a practitioner network ready to order, a first outside sales rep with 30 years of experience selling to practitioners, and clinical credibility no competitor on the platform can match.
Platform — Fullscript
The primary ordering platform for functional medicine practitioners across North America. Patients cannot purchase directly — ensures the practitioner relationship stays intact.
Dr. Jocelyn Strand, ND — VP Education
Onboarded April 2026. Brings an active practitioner network ready to order on day one. Clinical credibility that no competitor on Fullscript has matched.
First Outside Sales Rep
30 years selling to practitioners. Started March 2026 on commission. Covered 2 major trade shows in April — $70K–$100K in expected channel sales already funded.
Dartmouth Children's Hospital
Dr. Matthew Hand (Section Chief, Pediatric Nephrology) in active discussions to embed Immune Ready Kids directly into hospital clinical protocols via Fullscript. 500+ practitioners across the network.
This channel barely existed 18 months ago. Today it has two confirmed customers, a global distribution partner, and IP licensing in development. The ingredient is so defensibly superior that once a B2B buyer sees the head-to-head data, the decision is simple.
Lumati — the celebrity longevity clinic (Tony Robbins, Justin Timberlake) — had been using a competitor's beta glucan. We ran the Větvička comparison. BWH-85® came back 64× more effective. Their first order was $40,000. That was Dec 2025 — the first-ever B2B raw ingredient sale in BWH's history.
TSI Group (makers of myHMB® and Velositol®) confirmed May 2026. Global distribution. They're incorporating BWH-85® directly into their formulations. This is the second confirmed B2B customer and a significantly larger player than Lumati.
Lumati
Celebrity longevity clinic. Private label 500mg + 100mg capsules + raw BWH-85® powder. Switched from a competitor after head-to-head data showed BWH-85® 64× more effective.
$40,000 first order · Dec 2025
TSI Group Ltd
Makers of myHMB® and Velositol® — two of the most widely distributed sports nutrition ingredients globally. Incorporating BWH-85® into their formulations. Global distribution reach.
Global reach · Significant scale validation
Every other channel sells beta glucan as an immune health ingredient. Skin care would be something different entirely — beta glucan as a topical, dermatological active. A new customer, a new market, a new use case for the same defensible IP.
This is the dashed line on the strategy whiteboard from May 2026. It isn't resourced yet. But the science is there — six peer-reviewed studies showing collagen synthesis stimulation, cellular proliferation, and wound healing applications.
The Replenishment Cream (currently in D2C) is the proof of concept — beta glucan applied topically is already working in BWH's existing product line. The question is whether to build a standalone skin care brand around that mechanism. That conversation is happening now.
6
Peer-reviewed studies on topical beta glucan applications
+35%
Collagen synthesis increase in controlled dermatology studies
87.5%
Early survival rate — Replenishment Cream (cold traffic, Feb 2026)
29.1×
LTV:CAC on the Replenishment Cream — highest in the product line
Immune health targets one customer segment. Skin care is a completely different demographic — the anti-aging and dermatology market is 5× larger. The same BWH-85® IP, the same science moat, a completely new buyer.
The conservative base case is already $7M. These are the individual opportunities that each could add $500K–$2M in annual revenue on their own.
60 patients. BWH-85® at 1,000mg/day. Measurable biological age reversal in 7 of 11 organ systems. Publishing in Frontiers in Nutrition. Upon publication: dedicated longevity webinar funnel targeting the fastest-growing, highest-spending consumer health segment.
Publishing Now · Funnel ReadyWorking with Jonathan Emord — one of the most successful FDA attorneys in the US — to pursue a federally recognized qualified health claim on BWH-85®. No marketing budget can replicate this. Permanently transforms pricing power, distribution access, and business valuation.
In Progress · $150K InvestmentDr. Matthew Hand (Section Chief of Pediatric Nephrology) wants to embed Immune Ready Kids directly into hospital clinical protocols via Fullscript — inside their EMR system. 500+ practitioners across the network.
Active DiscussionsTSI Group makes myHMB® and Velositol® — two of the most widely distributed sports nutrition ingredients globally. They're now incorporating BWH-85® into their formulations. First time BWH-85® gets global B2B ingredient distribution.
Confirmed May 2026A largely untouched market. Mark Hicks is leading. The model: run a study, take results to all LTC facilities simultaneously. Immune health in aging populations is one of the most compelling clinical applications for BWH-85®.
Early · Mark Hicks LeadingA separate entity from BWH (kept apart for FDA compliance). Becoming the AI-powered ultimate reference on beta glucan research — covering cancer, heart disease, aging — topics the commercial site can't touch.
Active · BuildingKevin, Reggie, AJ Lanigan, and John Quilter sat together in December 2023. One question: what would it actually take to turn this into a real company?
Three things had to happen. Two are done. One is in motion. The plan from that meeting is the business you're looking at today.
You've got the best ingredient in the world and you've got the science. You need supply chain security, clinical education, and someone who can sell to practitioners. Build those three and you have a $20M business.John Quilter — December 2023
Lock the supply. Own the purity standard.
Kinjal Desai joined as VP of Operations. Secondary supplier qualification underway. KSU strain development in progress. BWH-85® purity standard codified and trademarked across five global markets.
Put a credentialed educator at the center.
Dr. Jocelyn Strand, ND joined as VP of Education in April 2026. Her practitioner network was ready to order on day one. BWH Labs now has a clinical face that no competitor on Fullscript has matched.
Put a seasoned rep in front of practitioners.
First outside sales rep — 30 years selling to practitioners — started March 2026 on commission. Covered 2 major trade shows in April. $70K–$100K in expected channel sales already funded.
In February 2026, Joe Bricker committed $1M against a specific execution plan. Every dollar was earmarked before he wired it. This is where it went.
BWH Labs live on Fullscript with VP Education onboard
TruDiagnostic study results in — publishing in Frontiers in Nutrition
Warehouse operational — 3PL costs eliminated
FDA qualified health claim in progress with Jonathan Emord
BWH Labs — Practitioner Brand
Fullscript launch, Dr. Strand, first sales rep, trade shows, collateral
FDA Qualified Health Claim
Jonathan Emord engagement — pursuit of federally recognized claim
TruDiagnostic Longevity Study
60-patient biological age reversal study — publishing in Frontiers in Nutrition
In-House Fulfillment Center
The Barn warehouse build-out — full operational independence from 3PL
Staffing
Operational team expansion to support growth phase
Strategic Advisors
John Quilter, business architecture, M&A positioning
Stord — Fulfillment Transition
3PL → in-house migration; eliminated ongoing per-order logistics cost
KSU Strain Development
Kansas State University — secondary strain research and qualification
Three years of unglamorous infrastructure decisions. Supply chain, fulfillment, cost structure — none of it is photogenic. All of it is why the margins are what they are.
Supply Chain
Primary + secondary supplier qualification. KSU strain development. Purity verified at 85%+ minimum — 15 points above the competitive average.
Purity & IP
BWH-85® registered June 2026. BWH-90™ filed. 5 jurisdictions: US, UK, EU, China, India. The "85" is a federally recognized purity standard, not a marketing claim.
Clinical Research
11 Větvička head-to-head studies. TruDiagnostic longevity study. FDA qualified health claim in pursuit with Jonathan Emord. 40+ KOL relationships.
Distribution
D2C (Shopify + Recharge) + Fullscript + Amazon + B2B ingredient + private label. In-house fulfillment at The Barn. Five live channels simultaneously.
Education & Sales
40+ webinar topics. Studio 85 production facility. VP Education onboard. First practitioner sales rep active. Clinical KOL network expanding weekly.
The Warehouse
We built a full in-house fulfillment center at The Barn. $100,000 investment. Stord (our 3PL) cost was eating margin that compounded every quarter. We eliminated it.
The result: lower per-order cost, faster turnaround, full operational control. When you ship for 7,600+ active subscribers across 11,000+ subscription lines — plus one-time orders on top — owning fulfillment isn't optional. It's the margin.
The Cost Structure
Wave 1 (Oct–Feb): Identified $20–30K/month in overhead. Cut without touching operations. Margins moved immediately.
Wave 2 (Post-Marcus): Kevin's departure freed $250K in annual compensation plus $15K/month in additional overhead. The business became structurally leaner than it had ever been.
Same 12-month window: ROAS went from 1.4× to 3.5×+. Lower cost base plus better acquisition efficiency. The margin profile you see today is a direct result of that work.
Three independent valuation lenses. All three converge in the same neighborhood. This is what the business is worth right now — before the FDA health claim, before TSI scale, before the longevity funnel, before Dartmouth.
$19M–$30M
$7.7M ARR × 2.5–4.0×. SaaS-comparable multiples for a subscription health brand with 9–11× LTV:CAC, demonstrated low churn, and no single-customer concentration risk.
$14M–$22M
$6.3M 2025 revenue × 2.2–3.5×. Conservative for a brand with demonstrated subscription stickiness, a proprietary trademarked ingredient, and five active distribution channels. This is the floor.
Top Decile
9–11× LTV:CAC. CAC payback under 2 months. Mature subscriber cohorts at 2.2% monthly churn after 6–8 years on product. Acquirers in health & wellness pay significant premiums for this cohort profile.
There are two ways to think about this. The fundamentals — what the business is worth based on exactly where it stands today. And the future — what that number becomes when the qualified health claim lands, when TSI scale comes through, when the longevity funnel goes live. You are not being asked to pay for the future. You're being invited to get in before the market prices it.From the Bricker Investment Memo — February 2026
You came in through BWH Labs — the practitioner channel. What you haven't had visibility into is everything upstream and downstream of it. The D2C machine that generates the capital. The webinar engine that acquires subscribers at a 9–11× LTV:CAC ratio. The B2B ingredient plays that create a market floor. The research moat that no competitor can replicate without 26 years of relationships.
The question isn't whether BWH is worth investing strategic partnership resources in. The question is: where does your involvement have the highest leverage?
01
The practitioner market for functional supplements is $250B+. BWH Labs has the only practitioner-exclusive beta glucan brand on Fullscript with a clinical proof stack that no competitor has. Ovation Lab's expertise in HCP brand building is exactly what BWH Labs needs to go from a good idea to a dominant market position. Target: 30% of total BWH revenue from practitioner channel within 36 months.
02
We can't build everything at once. The cream funnel, the longevity funnel, the LTC channel, the Dartmouth protocol, the B2B ingredient play — all of these have real ROI. The hardest problem is sequencing. Your perspective across the health industry — where capital, attention, and timing create compounding returns — is the resource we need most right now.
03
The TSI deal validates that the B2B ingredient channel is real. The Lumati deal validates celebrity/longevity. The Dartmouth discussion validates institutional health systems. What we're looking for are introductions to the right investors, distribution partners, and practitioners — people who can see the size of what BWH-85® can become before the mainstream breaks.
We own the research. The trademark. The brand. Five channels. The warehouse. The one thing we still buy from someone else is the beta glucan. The next chapter of BWH-85® is making it ourselves — on American soil, start to finish.
What It Costs Us Today
Levapan · Colombia
Our beta glucan is produced at Levapan in Colombia — a plant Michael Catto, the engineer below, helped design and build.
Keri — $375 / kg
A.J. Lanigan's landed cost on the finished molecule from his source.
A.J. Lanigan — +$200 / kg
$200/kg added before the product ever reaches us.
$575 / kg
What we pay today. Across A.J. Lanigan and BWH combined, that's roughly 4,000 kg a year — and climbing.
Own The Molecule
With our own facility, the same kilogram that costs us $575 today drops to under $150 — fully loaded. No source markup. No intermediary margin. No supply chain we don't control.
And it isn't only about cost. It's complete control of supply and quality — the last piece of vertical integration BWH doesn't yet hold. When the molecule is ours end to end, the moat is closed.
At 10,000 kg a year, that spread is over $4.25M in annual savings — enough to pay back the entire build in roughly a year of production.
The Engineer
Michael Catto is a process engineer who has designed, deployed, and built manufacturing plants across the world — including Levapan in Colombia, the very facility producing our beta glucan today.
He's 75 and retired. But the relationship runs deep enough that he's willing to come back and architect a beta glucan facility for Better Way Health when the volume is there.
This isn't a someday idea. We've already hired Mike to build the estimates and engineering plans — the blueprint below is his work. And it's modular by design: we build one production line, then scale by adding lines as demand grows.
The proposed facility will leverage advanced extraction and purification techniques, enabling the production of Beta Glucan with high bioavailability — and the investment will support Better Way Health's vision of fostering innovation.Michael Catto · Process Engineer · July 2025
The Blueprint
Mike's estimate for a complete 5,000 kg/year processing line — equipment, piping, utilities, and installation. Every stage priced from real used food and pharma equipment sourced across the USA.
Fermentation
2,000 L SS316 fermenter, aeration, agitation, and primary disc-stack centrifuge
Cell Harvesting
1,500 L/hr disc-stack centrifuge and two jacketed yeast tanks
Cell Wall Disruption
Autolysis tank, alkaline & acid reactors, pH adjustment, steam heating, transfer pumps
Beta Glucan Extraction
Plate-and-frame filter press and 800 L ultrafiltration system
Concentration
500 L/hr falling-film vacuum evaporator and transfer pump
Spray Drying
Niro rotary-atomizer spray dryer and 60 m³ stainless storage silo
Packaging
Ribbon blender, 45k caps/hr filler, electronic counter, capper, labeler, case packer
Interconnecting Piping
316 SS sanitary piping and fittings throughout the line
Utilities & Facility Setup
Steam, water, chilled water, air, electrical, filtration, waste, and baghouse discharge
Construction & Installation
Full equipment installation, assembly, and operational launch
Total Equipment & Build-Out
$4,503,900
Equipment, piping, utilities, and installation only. Excludes the building itself (anticipated to be leased) and engineering. Estimate prepared by Michael Catto, July 2025.
The Path
Feasibility & Site Selection
3–6 months
Facility Design & Permitting
6–12 months
Construction & Equipment Installation
8–12 months
Staff Training & Operational Launch
2 months
When It Pencils Out
We use about 4,000 kg a year today. For an owned facility to make financial sense, we need to be running 10,000–15,000 kg a year — and growing faster than we are now.
So this is a milestone, not a line item. The point isn't that we break ground this quarter. The point is that when the volume arrives, the engineer, the blueprint, and the supply-chain independence are already ours — while every competitor is still buying commodity powder at someone else's markup.
We spent 26 years earning the relationships that let us buy the best beta glucan in the world. The last chapter is not buying it at all — it's making it ourselves, in America, end to end.The Future of BWH-85®
The Thesis
26 years of relationships. 11 published comparison studies. Five channels. A trademarked ingredient. A $7.7M ARR subscription base. A webinar system that converts cold traffic at 9–11× LTV:CAC. A clinical proof stack that no competitor has bothered to build. We've been building the moat while everyone else has been selling commodity powder.
The infrastructure is here. The question is how fast we move.
— Reggie Black
CEO, Better Way Health · May 2026